Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125970572 | 12597057 | 2 | F | 20160421 | 20160801 | 20160726 | 20160816 | EXP | US-SAOL THERAPEUTICS-2016SAO00234 | SAOL THERAPEUTICS | 56.12 | YR | F | Y | 0.00000 | 20160816 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125970572 | 12597057 | 1 | PS | BACLOFEN. | BACLOFEN | 1 | Intrathecal | UNK | 20075 | INJECTION | |||||||||
| 125970572 | 12597057 | 2 | SS | FENTANYL. | FENTANYL | 1 | Intrathecal | 0 | |||||||||||
| 125970572 | 12597057 | 3 | SS | FISH OIL | FISH OIL | 1 | 0 | ||||||||||||
| 125970572 | 12597057 | 4 | SS | MACRODANTIN | NITROFURANTOIN | 1 | 0 | ||||||||||||
| 125970572 | 12597057 | 5 | SS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125970572 | 12597057 | 6 | SS | AMPYRA | DALFAMPRIDINE | 1 | 0 | ||||||||||||
| 125970572 | 12597057 | 7 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 125970572 | 12597057 | 8 | SS | VESICARE | SOLIFENACIN SUCCINATE | 1 | 0 | ||||||||||||
| 125970572 | 12597057 | 9 | SS | FLONASE | FLUTICASONE PROPIONATE | 1 | 0 | ||||||||||||
| 125970572 | 12597057 | 10 | SS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125970572 | 12597057 | 11 | SS | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125970572 | 12597057 | 12 | SS | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | 0 | ||||||||||||
| 125970572 | 12597057 | 13 | SS | MULTIVITAMIN | VITAMINS | 1 | 0 | ||||||||||||
| 125970572 | 12597057 | 14 | SS | FOSAMAX | ALENDRONATE SODIUM | 1 | 0 | ||||||||||||
| 125970572 | 12597057 | 15 | C | GABAPENTIN. | GABAPENTIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125970572 | 12597057 | 1 | Muscle spasticity |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125970572 | 12597057 | HO |
| 125970572 | 12597057 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125970572 | 12597057 | Multiple sclerosis relapse | |
| 125970572 | 12597057 | Pain | |
| 125970572 | 12597057 | Performance status decreased | |
| 125970572 | 12597057 | Sensory loss |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |